UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012799
Receipt number R000014951
Scientific Title Examination of protective efficacy of influenza by zanamivir among the staff of a medical facility
Date of disclosure of the study information 2014/01/09
Last modified on 2014/01/09 02:30:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of protective efficacy of influenza by zanamivir among the staff of a medical facility

Acronym

Protective efficacy by zanamivir in a medical facility

Scientific Title

Examination of protective efficacy of influenza by zanamivir among the staff of a medical facility

Scientific Title:Acronym

Protective efficacy by zanamivir in a medical facility

Region

Japan


Condition

Condition

influenza

Classification by specialty

Infectious disease Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To make sure whether zanamivir has protective efficacy among the staff in medical facilities

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

incidence of influenza-like illness

Key secondary outcomes



Base

Study type


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

prophylactic administration of zanamivir

Interventions/Control_2

administration of pracebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

the staff who;

1.works in Shizuoka Kosei Hospital and collaboration facilities
2.works the day shift
3.gives written informed concent

Key exclusion criteria

the staff who;

1.has specific medical history
Ex.1 asthma
Ex.2 other pulmonary diseases
Ex.3 taking medications affecting immune system
2.shows difficulty in inhalation of zanamivir
3.is considered unsuitable by a responsibil doctor

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshihiro Tanaka

Organization

Shizuoka Kosei Hospital

Division name

Department of Pediatrics

Zip code


Address

23 Kitaban-cho, Aoi-ku, Shizuoka-city, Japan

TEL

054-271-7177

Email

toshihiro.tanaka@alumni.utoronto.ca


Public contact

Name of contact person

1st name
Middle name
Last name Toshihiro Tanaka

Organization

Shizuoka Kosei Hospital

Division name

Department of Pediatrics

Zip code


Address

23 Kitaban-cho, Aoi-ku, Shizuoka-city, Japan

TEL

054-271-7177

Homepage URL


Email

toshihiro.tanaka@alumni.utoronto.ca


Sponsor or person

Institute

Shizuoka Kosei Hospital

Institute

Department

Personal name



Funding Source

Organization

Shizuoka Kosei Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

静岡厚生病院


Other administrative information

Date of disclosure of the study information

2014 Year 01 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2013 Year 11 Month 22 Day

Date of IRB


Anticipated trial start date

2014 Year 01 Month 20 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 01 Month 09 Day

Last modified on

2014 Year 01 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014951


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name